Mirie Zerbib

Medicine · Health Sciences

14h-index4.6kcitations109works0.72yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(77), Immunotherapy and Immune Responses(47), Prostate Cancer Treatment and Research(34), Single-cell and spatial transcriptomics(28), Cancer Genomics and Diagnostics(26)

Publications109 total

Supplementary Table S5 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
Supplementary Table S11 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
Supplementary Table S14 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
Supplementary Figure S7 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
Supplementary Table S1 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
Supplementary Figure S2 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
Supplementary Table S3 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
Supplementary Figure S6 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
Supplementary Table S7 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
Supplementary Table S4 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
Supplementary Table S2 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
Supplementary Table S12 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
Supplementary Figure S4 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
Supplementary Figure S1 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
Supplementary Table S16 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
Supplementary Table S8 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
Supplementary Table S13 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
Supplementary Figure S5 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
Supplementary Table S15 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
Supplementary Table S10 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
2026Open Access
page 1 of 6Next →

Frequent Co-authors

Roni Oren(30), Chen Weller(27), Nofar Gumpert(27), Ronen Levy(26), Elizabeta Yakubovich(26), Yishai Levin(20), Sergey Viukov(18), Noa Novershtern(18), Jacob H. Hanna(18), Vladislav Krupalnik(17), Shira Sagie(17), Polina Greenberg(17), Gil Benedek(17), Maria Dayan-Rubinov(16), Talya Wasserman-Bartov(16), Jianhui Gong(16), Ryan J. Rebernick(16), Almudena Tercero(16), Merav Kedmi(16), Alexander W. Wyatt(16)